Trial intelligence / Profile preview

Hyperpolarized Xe MR Lung Imaging in HSCT and Rare-Lung Disease Patients

NCT07823036Phase 2Recruiting

Sponsor
Cincinnati Children's Hospital Medical Center
Start
Jul 2024
Primary completion
Jul 2029
Countries
1
01

Overview

A Phase 2 trial of hyperpolarized xenon gas in Respiratory Disease (RD), sponsored by Cincinnati Children's Hospital Medical Center. Started Jul 2024; status: recruiting.

02

Drugs

hyperpolarized xenon gas
03

Conditions

Respiratory Disease (RD)

Beyond the preview

Go deeper on NCT07823036.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07823036.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call